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Abstract
Background: Earlier we identified ten 100-300-bp long CTCF-binding DNA fragments selected earlier from a 1-Mb
human chromosome 19 region. Here the positive-negative selection technique was used to check the ability of
CTCF-binding human genomic fragments to block enhancer-promoter interaction when inserted into the genome.
Results: Ten CTCF-binding DNA fragments were inserted between the CMV enhancer and CMV minimal promoter
driving the herpes simplex virus thymidine kinase (HSV-tk) gene in a vector expressing also the neo
R gene under a
separate promoter. The constructs were then integrated into the genome of CHO cells, and the cells resistant to
neomycin and ganciclovir (positive-negative selection) were picked up, and their DNAs were PCR analyzed to
confirm the presence of the fragments between the enhancer and promoter in both orientations.
Conclusions: We demonstrated that all sequences identified by their CTCF binding both in vitro and in vivo had
enhancer-blocking activity when inserted between the CMV minimal promoter and enhancer in stably transfected
CHO cells.
Background
Spatial, temporal and tissue specific gene expression in
mammals is largely determined by genomic cis-regulatory
elements, such as promoters, enhancers, silencers, and
insulators (for recent review, see [1,2]). A survey of about
1% of the human genome [3] indicated that the regulatory
elements were more abundant in the genome than the
genes they control and are mostly distal to the genes that
they regulate.
While the number and positions of enhancer elements
in the whole human genome can be determined with
some certainty through P300 binding [4], the number and
positions of most insulator elements are not known [2],
and methods of their identification in mammals are sparse.
Moreover, the definition of insulator is somewhat ambigu-
ous–this term designates elements with enhancer-blocking
or chromatin-bordering functions (reviewed in [5]) which
are not interrelated at least in some cases [6,7]. In addi-
tion, the term “insulator” is sometimes used to designate
the elements that bind the CTCF protein but have no pro-
ven enhancer-blocking or chromatin-bordering activity.
Two basic approaches have been proposed to identify
many potential genomic insulators in one experiment.
One approach is based on the ChIP-on-chip or ChIP-seq
techniques with antibodies to known insulator-binding
proteins, like CTCF or CP190 [8-10]. This approach can
be used for the whole-genome analysis, but has a draw-
back that binding of a certain protein may be insufficient
for insulator activity, which may result in many false posi-
tives. Another approach is based on a functional enhan-
cer-blocking test in stably transfected cells [11,12] but is
applicable to only relatively short (several megabases)
genomic sequences.
It is well known that most mammalian insulators (with
some exceptions reported [13-15]) bind CTCF (for review,
see [16,17]). However, it was shown that CTCF has many
other genomic functions apart from insulator [17].
Earlier we developed a positive-negative selection
method allowing identification of insulators based on
their ability to prevent promoter activation by enhancer
when located between them [11]. We constructed a
pPNT/EmP plasmid [11,12] containing the neomycin-
resistance gene under control of the mouse phosphogly-
cerate kinase promoter (mPGK1) and the herpes simplex
virus thymidine kinase (HSV-tk) gene under control of
the CMV minimal promoter and CMV enhancer. HSV-tk
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any medium, provided the original work is properly cited.catalyzes phosphorylation of ganciclovir to the monopho-
sphate [18,19] which is further converted into the tripho-
sphate by cellular enzymes and incorporated into
growing DNA chain causing termination of replication
and cell death [20,21].
The pPNT/EmP plasmid efficiently expresses the HSV-
tk gene. However, after insertion into pPNT/EmP of a
DNA fragment capable of blocking the interaction
between the CMV promoter and enhancer, the HSV-tk
expression in cells stably transfected with this plasmid
gets significantly reduced and the cells become resistant
to ganciclovir.
Using this principle, we developed a technique and used
it for identification and mapping of 18 enhancer-blocking
DNA elements within the FXYD5-COX7A1 region of
human chromosome 19. This region contains more than
40 characterized genes with different expression profiles,
and the data obtained allowed us to make conclusions on
the mutual arrangement of enhancer-blocking sequences
and genes and their possible functional interactions
[11,12].
In this work, we studied the relationship between
CTCF binding and enhancer-blocking activity of 10
CTCF-binding genomic fragments identified earlier in
our laboratory [22]. Using a functional test described
above, we demonstrated that all fragments which bind
CTCF both in vitro and in vivo were capable of blocking
activation of the CMV minimal promoter by the CMV
enhancer in stably transfected CHO cells.
Methods
Basic protocols
Growth and transformation of E. coli cells, preparation
of plasmid DNA, agarose gel electrophoresis, blot-hybri-
dization and other standard manipulations were per-
formed as described [23].
Constructs
Ten in vitro CTCF-binding DNA fragments cloned pre-
viously in pGEM-T (Promega) [22] were cut out with
Xho I and inserted in both orientations into pPNT/EmP
[11] using Sal I site located between the CMV enhancer
and minimal promoter.
A pPNT/mP plasmid containing the HSV-tk gene under
control of the CMV minimal promoter and conferring
resistance to neomycin and ganciclovir on transfected cells
[11] was used as one of positive controls. Another positive
control was a pPNT/E-sns-mP plasmid containing the sea
urchin Paracentrotus lividus sns insulator between enhan-
cer and promoter [24,25]. To prepare this construct, a pBS
KS + plasmid, kindly provided by R. Melfi and G. Spinelli
(University of Palermo, Italy), was cut with HindI I Ia n d
Sma I, treated with Klenow enzyme to fill in the sticky
ends, and a ~300 bp fragment containing the sns insulator
was isolated by agarose gel electrophoresis. The sns-con-
taining fragment was inserted in both orientations into
pPNT/EmP cut with Sal I and treated with Klenow
enzyme.
A negative control pPNT/E-l-mP plasmid was prepared
by insertion of a lambda phage fragment PCR-amplified
with Xho I site-containing primers ACTCGAGTCCGT-
GAGGTGAATGTG and ACTCGAGTAGTCGGCT-
CAACGTGG into SalI-digested pPNT/EmP.
The constructs obtained are shown in Figure 1. Prior
to electroporation, the constructs were linearized with
Eco47 III (Fermentas).
To reveal possible silencer activity of CTCF-binding
fragments, the Sal I recognition site of the pPNT/EmP
plasmid was inactivated by Sal I digestion and filling in
the sticky ends with Klenow enzyme followed by self-liga-
tion. The plasmid was then cut with PspE I (SibEnzyme),
and double-stranded adapter (a hybrid of GTCAC-
CAATTGTCGACGGATCC and GTGACGGATCCGTC-
GACAATTG) containing a Sal I site (underlined) was
inserted 3’ to the HSV-tk gene. The resulting plasmid
(pPNT/EmPS, Figure 1) was used for insertion into the
novel Sal I site of CTCF-binding fragments ## 3, 7 and 8.
Prior to electroporation, the constructs were linearized
with Ssp I (Fermentas).
Cell culture and transfection
CHO-K1 cells (CCL-61, Chinese hamster ovary cells) were
grown under conditions recommended by ATCC. Electro-
poration was performed using a Gene Pulser Xcell
(BioRad) system as described previously [11], the trans-
fected cells were inoculated into 5 ml of growth medium
and incubated for 48 hours. The medium was then
replaced with fresh culture medium supplemented with
500 ug/ml of G418 (Geneticin, Gibco-BRL), and the cells
were cultured for 2 weeks in the presence of this antibio-
tic. An aliquot of the cell suspension was taken for geno-
mic DNA isolation, and residual cells were cultured for
2m o r ew e e k sa f t e ra d d i t i o no f4o r1 0u Mo fG A N C
(Sigma). The G418 and GANC resistant cells were then
collected, and genomic DNA isolated using a Wizard
Genomic DNA Purification Kit (Promega).
PCR
The first stage of nested PCR was performed using a 20 ng
genomic DNA template and primers matching the 5’ and
3’ flanks of the insertion site (Sal I). Structures of the pri-
mers are presented in Table 1. Primers P1L and P1R were
used for pPNT/EmP based constructs and primers P2L
and P2R - for pPNT/EmPS based constructs. The first
stage product was diluted 4-fold and 1 ul thereof was used
as a template for the second stage, where each individual
internal primer was used in combination with either P1L
or P1R in order to determine both the presence and
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DNA (see Table 2). PCR was performed for 20-25 cycles
at the first stage and 25-35 cycles at the second stage
using the following profile: 94°/30 s; 60°/30 s; 72°/50 s.
Real-time quantitative PCR (qPCR) was performed using
an MX3000P cycler (Stratagene) and qPCRmix-HS SYBR
(Evrogen) in a 25 ul reaction volume for 40 cycles with the
following profile: 95°C for 30 s, 65°C for 20 s, and 72°C for
30 s. The following primer pairs were used: GGCGTGGA-
TAGCGGTTTGACT and GGCACTGTCCTCAGCGT
CTCTC to reveal the pPNT/E-CTCF7-mP construct,
GGCGTGGATAGCGGTTTGACT and ACGGATGGT-
GATGCCGAGAAC to reveal the pPNT/E-l-mP con-
struct, and ACTACGGCATCTCTGCCCCTTC and
GGCACTGTCCTCAGCGTCTCTC to reveal the pPNT/
EmPS-CTCF7 construct.
The relative DNA content was calculated according to
the formula:
C =1

(2E)
Nn−Ng
where C is the relative DNA content, E-efficiency of
the primer pair, and N is the number of PCR cycles
required to detect the target on templates isolated after
Neo selection (Nn) or after Neo and ganciclovir selec-
tion (Ng).
The DNA contents of different constructs were nor-
malized to that of pPNT/E-CTCF7-mP.
Results
The following constructs were prepared from the pPNT/
EmP plasmid (see Figure 1): (i) a pPNT/mP plasmid lack-
ing the CMV enhancer; (ii) a pPNT/E-sns-mP plasmid,
where the sns (silencing nucleoprotein structure) insula-
tor from the sea urchin Paracentrotus lividus [24,25] was
cloned in both orientations between the CMV enhancer
and promoter. The sns insulator was kindly provided by
G. Spinelli and R. Melfi (University of Palermo, Italy); (iii)
a pPNT/E-l-mP plasmid in which, instead of the sns
insulator, a fragment of phage lambda DNA was placed
between the CMV enhancer and promoter. In addition,
the pPNT/EmPS control plasmid was prepared that
Figure 1 Plasmid constructions used in this work.m P G K - 1 - m o u s ep h o s p h o g l y c e r a t ek i n a s eIp r o m o t e r ;Neo
R-E. coli neomycin
phosphotransferase gene; HSV-tk-herpes simplex virus thymidine kinase gene. Broken arrows indicate direction of transcription. For detailed
description, see the text.
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promoter-enhancer region thus making it possible to
detect silencer activity of DNA fragments.
CHO cells were electroporated with these constructs
followed by incubation for 48 h, addition of G418 and
then positive selection for 12-14 days. In these condi-
tions, non-electroporated control cells died within 7
days.
Once the selection was complete, an aliquot was taken
from each selected sample for genomic DNA isolation,
and the remaining cells were subjected to negative selec-
tion by addition of 4 or 10 micromoles of ganciclovir. At
both ganciclovir concentrations, complete cell death was
observed in samples transfected with the pPNT/EmP and
pPNT/E-l-mP plasmids, whereas in samples transfected
with pPNT/mP and pPNT/E-sns-mP a significant portion
of cells were resistant to the ganciclovir treatment. The
partial cell death in these samples can be due to the activa-
tion of the HSV-tk promoter by endogenous cellular
enhancers.
After the positive-negative selection, genomic DNA
was isolated from the pPNT/E-sns-mP transfected cells
and used to determine the presence and orientation of
the sns insulator inserts by PCR amplification (Figure 2).
The primer pairs for amplification of the sns insulator in
both orientations and their sequences are presented in
Tables 1 and 2. As seen from Figure 2, the PCR produced
DNA fragments of the expected lengths, which means
that the HSV-tk expression in the transfected cells was
suppressed or significantly reduced, and that the sns ele-
ment in CHO cells was active as enhancer blocker in
both orientations.
Therefore, the control experiments confirmed that the
system developed could be used for selection of enhan-
cer-blocking sequences.
Enhancer-blocking activity of the CTCF-binding DNA
fragments
To check the enhancer-blocking ability of ten CTCF-
binding human genomic fragments identified earlier in
our laboratory [22], we cloned them into pPNT/EmP
between the cytomegalovirus enhancer and promoter.
Since enhancer-blocking activity of some insulators was
Table 1 Sequences of PCR primers
Fragment ID Primer ID Sequence
1 1L GTTTGTGACCTGTGCCCTTT
1R GAGGCCCCGACTCTTAACTC
2 2L AGGTCCCTTCTCTCCCTGCT
3 3L AATGATATTCCTCACGGCACT
4 4L GCTCTGGGAAGAAACCACAG
4R GCAGGAGCAAGGTGAGATG
5 5L GCTTTCTGACCCGCCTTT
6 6L ATAGAGAAGCAGGGGGTGTG
6R TGCTGTTCCGTAATAACTTGCT
7 7L CACTAATGAGAGACGCTGAGGA
7R GCTTCTGGAGGGTGTTTCTG
8 8L CACTTTCTCCCACACTTCCA
8R CACCGTCCTCTGCCAACT
9 9R AAGGCACTGGCATCCTGTCT
10 10L GTACAGCCCTGGAGCAAGGAC
sns snsL ACTCGCAAACCTCAACACCT
snsR CAAAACTGGAATGGGGAAGA
Plasmid P1L GGATTTCCAAGTCTCCAGGGGAT
primers P1R ACCTCCCACCGTACACGCCT
Plasmid P2L CCGGACGAACTAAACCTGAC
primers P2R TGTAGGTACTCTGTTCTCACCCTTC
Table 2 Primer pairs for identification of CTCF-binding sequences in direct and reverse orientation
Fragment ID Combination of primers*
Direct orientation Reverse orientation
pPNT/EmP pPNT/EmPS pPNT/EmP pPNT/EmPS
1 P1R, 1L (522) P1R, 1R (286)
2 P1R, 2L (268) P1L, 2L (290)
3 P1R, 3L (233) P2R, 1L (319) P1L, 3L (255)
4 P1R, 4L (346) P1R, 4R (317)
5 P1R, 5L (307) P1L, 5L (329)
6 P1R, 6L (447) P1R, 6R (320)
7 P1R, 7L (292) P2R, 7L (378) P1R, 7R (305)
8 P1R, 8L (341) P1R, 8R (330) P2R, 8L (416)
9 P1L, 9R (267) P1R, 9R (245)
10 P1R, 10L(557) P1L, 10L (579)
sns P1R, snsL (354) P1R, snsR (368)
*Expected PCR product lengths (bp) are indicated in parentheses
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containing the 10 fragments in different orientations rela-
tive to the promoter were prepared. For transfection, all
20 plasmids were linearized and pooled in equal
amounts. The same amount of pPNT/E-sns-mP, contain-
ing the sns insulator in both orientations, was added to
the pool as an internal control.
In this work we used the CHO cell line successfully
employed earlier for selection of enhancer-blocking
sequences [11,12]. These cells are advantageous for the
selection because they are highly sensitive to ganciclovir
and can be efficiently transfected by electroporation.
Moreover, it was shown that insulators from the genome
of one species can maintain their activity in the cells of
other species. In particular, the 5’-HS4 chicken beta-glo-
bin insulator is active in human K562 cells [27], and the
sea urchin sns insulator can block enhancer-promoter
interactions in human osteosarcoma cells U2-OS and
human lung adenocarcinoma cells H1299 [24]. It was
also shown that human CTCF can bind to corresponding
sites in the mouse genome [28].
CHO cells were transfected with the plasmid pool by
electroporation using conditions established previously to
provide integration of a single plasmid copy into the cell
genome [29], and then subjected to positive-negative
selection as described above. The survived cells were
used to isolate genomic DNA.
The genomic DNA was used as a template for nested
PCR. At the first stage, the fragments located between
the CMV promoter and enhancer were amplified with
primers P1L and P1R (Figure 1). The PCR product con-
tained a mixture of selected CTCF-binding fragments
flanked by short fragments of the pPNT/EmP DNA.
This mixture was used as a template for the second
PCR round with internal primers specific for each
CTCF-binding fragment and the control sns insulator
(Table 2). Each individual internal primer was used in
combination with either P1L or P1R in order to deter-
mine both the presence and orientation of the CTCF-
binding fragments in the selected DNA. The results of
nested PCR are presented in Figure 3. As seen from Fig-
ure 3A,B (upper panels), all 10 CTCF-binding fragments
and the control sns insulator were present in the geno-
mic DNA after G418 selection suggesting that the corre-
sponding constructs were inserted into the cellular
genome. The same fragments were revealed also after
selection with 10 uM (Figure 3A,B, lower panels) or 4
uM ganciclovir (not shown). Therefore, it can be con-
cluded that all 10 fragments which bind CTCF in vitro
make the cells resistant to ganciclovir when placed
between enhancer and promoter.
It should be noted that, apart from insulators, other
regulatory elements, silencers, might also confer resis-
tance to ganciclovir. However, silencers are known to
suppress promoter activity irrespective of their position
relative to the promoter [30]. Therefore, in the constructs
used, silencers would suppress also the activity of the
neomycin phosphotransferase promoter, and the trans-
fected cells would not survive positive selection [11].
Nevertheless, we checked possible silencer activity of
three (## 3, 7 and 8) CTCF-binding fragments by cloning
them into the pPNT/EmPS plasmid 3’ to the minimal
promoter (Figure 1). The cells transfected with these
constructs died at the negative selection stage suggesting
Figure 2 PCR products obtained using a genomic DNA template from transfected CHO cells after positive (G418) and positive-
negative (Ganciclovir) selection and primers specific to the sns insulator in direct (+) or reverse (-) orientation relative to the CMV
minimal promoter. M-DNA length marker (SibEnzyme).
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promoter and hence did not possess silencer activity.
Thus, these fragments could block the enhancer action
only when placed between promoter and enhancer.
To quantitatively estimate the efficiency of the CTCF
binding sequences selection, we pooled together three
constructs, namely pPNT/EmP with the CTCF7 frag-
ment inserted between the promoter and enhancer, and
two controls-pPNT/EmPS with the CTCF7 fragment
inserted outside the promoter-enhancer pair and
pPNTE-l-mP with the lambda phage fragment inserted
between the promoter and enhancer. This equimolar
mixture was subjected to positive-negative selection pro-
cedure described above. Genomic DNAs were then iso-
lated from Neo and ganciclovir resistant cells and used
as templates for real-time quantitative PCR. The results
are presented in Figure 4.
As seen from the figure, the relative DNA content
(measured as described in Methods) of the control con-
structs was 30-40 times lower than that of the CTCF
binding fragments. These data support high efficiency of
the selection procedure and open up the opportunity for
quantitative measurement of the enhancer-blocking
effects.
Discussion
It can be therefore concluded that all 10 fragments from
the FXYD5-COX7A1 region that bind CTCF in vitro
make cells resistant to ganciclovir when inserted
between enhancer and promoter, i.e. have enhancer-
blocking (insulator) activity irrespective of their orienta-
tion relative to the promoter. In addition, the enhancer-
blocking activity of the sea urchin sns insulator is also
independent on its orientation, supporting previous
Figure 3 PCR products obtained using a genomic DNA template from transfected CHO cells after positive (G418) and positive-
negative (Ganciclovir) selection and primers specific to 10 CTCF-binding DNA fragments. A-"direct”, and B-"reverse” orientation of the
fragments relative to the CMV minimal promoter. M-DNA length marker (SibEnzyme).
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orientation-dependent, there are multiple examples of
orientation-independent insulators [32-35].
Earlier we demonstrated [11] that 6 out of 8
sequences identified by their ability to block enhancer-
promoter interactions were capable of binding CTCF
both in vitro and in vivo. Here, we present the evidence
that all sequences under study identified by their CTCF
binding have an enhancer-blocking activity.
The CTCF binding and enhancer-blocking potential are
not necessarily interrelated, and at least enhancer-blocking
ability can exist without CTCF binding [13-15]. This
o b s e r v a t i o ni si nl i n ew i t hDrosophila data [36] showing
that different subclasses of insulators bind different pro-
teins, such as dCTCF, GATA, Su(Hw), or BEAF, and only
part of insulators bind dCTCF. On the other hand, the
large number of CTCF binding sites in the genome sug-
gests a wide CTCF versatility far exceeding just insulator
function and including context-dependent promoter acti-
vation/repression, hormone-responsive silencing, genomic
imprinting, and long-range chromatin interactions
(reviewed in [17]).
Recent genome-wide studies on CTCF occupancy in
different cell types shed light on general characteristics
of CTCF binding sites distribution with respect to posi-
tions of genes in the genome (see references in Table 3).
Table 3 shows that that there are cell-type specific dif-
ferences in occupancy, but it is still unclear whether
they are functionally significant or merely due to differ-
ences in computational and experimental procedures
used [37]. Although cell-type specificity of CTCF occu-
pancy is in apparent contradiction with the conclusion
that most insulator elements are not specific to indivi-
dual cell types [2], it is in line with the observation that
occupancy of CTCF sites is dependent on their DNA
methylation status (see [38] for review).
The negative-positive selection data on enhancer-
blocking sequences obtained in this study, together with
those reported by us previously [11,12], are summarized
in Table 3 along with the ChIP-chip and ChIP-seq data
Figure 4 Relative DNA content of three constructs: pPNT/E-CTCF7-mP that contains the CTCF7 fragment between the promoter and
enhancer, pPNT/EmpS-CTCF7 that contains the CTCF7 fragment outside the promoter-enhancer pair, and pPNT/E-l-mp–the control
construct with a lambda DNA fragment inserted between the promoter and enhancer in genomic DNA of CHO cells after positive-
negative selection. The relative content was estimated by real-time PCR based on the difference between the number of PCR cycles required
to detect the target (for detail, see Methods).
Table 3 Summary of the number and location of human potential enhancer-blocking elements
Cells Potential insulators (CTCF binding and
enhancer- blocking sites)
Intergenic Intronic or
exonic
Within ± 2 kb from
promoter
Technique used Ref.
IMR90 human
fibroblasts
13804 46% 34% 20% ChIP-chip [10]
Resting human
CD4+T-cells
28661 49% 36% 15% ChIP-Seq [9,39]
HeLa 19308 56% 37% 7% ChIP-Seq [9]
Jurkat 19572 55% 36% 9% ChIP-Seq [9]
Mouse embryonic
stem cells
39609 N/D N/D N/D ChIP-Seq [40]
HeLa/CHO 28 (84000/genome) 46% 36% 18% Positive- negative
selection
[11,12]
N/D-no data
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enhancer-blocking sequences among different genomic
regions examined by different techniques is very similar,
the number of the enhancer-blocking sites in the genome
calculated by extrapolation of the number within a 1000-
kb genomic region found by us is considerably higher
than genome-wide evaluations. It is difficult now to
ascertain the reason for this discrepancy. For instance,
negative-positive selection might detect additional
enhancer-blocking elements which do not bind CTCF.
Conclusions
We would like to note that although our data, as well as
data of other authors, provide more or less comprehen-
sive structural information; a great challenge is to trans-
late this information into the language of insulator
function. This challenge is to a large extent due to var-
ious mechanisms of action of different insulators and
cannot be resolved by a genome-wide approach. It
demands thorough analyses of candidate insulators to
reveal all components of the regulatory networks that
involve these regulatory elements. Proper techniques for
such analyses, as e.g. 3 C, 4 C and 5 C, are already
being intensively developed.
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